Find Out if You Qualify for a Financial Reward by filling out the form below.
Investigation Details
On May 3, 2024, Owens announced 1Q24 financial results that beat consensus estimates. Additionally, the Company reported Patient Direct revenue that was below expectations. Management blamed it on “unique challenges that occurred in the quarter.” Analysts commenting on the missed revenue noted 2024 may be even more back-half weighted than management already guided.
Following this news, Owens’s stock price fell by $6.30 per share, or approximately 26% to close at $18.21 per share.
| Ticker Symbol | Company Name | Join Deadline | Join |
|---|---|---|---|
| SUI | Sun Communities, Inc. | February 10, 2025 | Join |
| SAVA | Cassava Sciences, Inc. | February 10, 2025 | Join |
| APLT | Applied Therapeutics, Inc. | February 18, 2025 | Join |
| BIOA | BioAge Labs, Inc. | March 10, 2025 | Join |
| PCRX | Pacira BioSciences, Inc. | March 14, 2025 | Join |
| NVO | Novo Nordisk A/S | March 25, 2025 | Join |
| GO | Grocery Outlet Holding Corp. | March 31, 2025 | Join |
| NEM | Newmont Corporation | April 01, 2025 | Join |